Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.74 USD | +3.60% | +5.65% | +596.46% |
May. 14 | Stephens Starts Elevation Oncology With Overweight Rating, $8 Price Target | MT |
May. 02 | Elevation Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Official Publications
No official publication found
- Stock Market
- Equities
- ELEV Stock
- News Elevation Oncology, Inc.
- Official Publications